|
ecology, molecular virology, pathogenesis, sarscov-2 |
19 |
|
covid-19, biobank, viral characteristics, immunity, pathogenesis, antivirals |
17 |
|
emerging, infections, pathogenesis, vaccine, diagnostics, antiviral |
14 |
|
antiviral treatment, drug discovery, drug repurposing |
5 |
|
coronavirus, animal, hamster, model, covid-19 |
5 |
|
coronavirus, casein kinase 1, phosphoproteomics, antiviral, mers |
5 |
|
zika, virus, phosphoproteomics, casein kinase, antiviral |
5 |
|
anti-influenza agents, influenza virus rna polymerase |
4 |
|
zika, virus, antiviral, nanobody, antibody, treatment |
4 |
|
coronavirus, sars-cov-2, covid-19, antiviral, nanobody, treatment |
3 |
|
coronavirus, sars-cov-2, covid-19, lipidomics, diacylglycerol acyltransferase |
3 |
|
development, novel, inhibitors, combatting, sars-cov-2, infection |
3 |
|
glycolysis, antiviral, broad-spectrum, host-virus interaction, mouse model, pfkfb3 |
3 |
|
rna-dependent rna polymerase, fidelity, antiviral drug, broad-spectrum, mutation rate, polioviurs |
3 |
|
srebps, lipid metabolism, emerging human viruses, broad-spetrum, drug target |
3 |
|
covid-19, antiviral, rdrp, high throughput screening, drug discovery |
2 |
|
covid-19, main protease, antiviral |
2 |
|
covid19, sars-cov-2 s protein, ace2, mutagenesis and screening, protein-protein interaction, drug design |
2 |
|
pulmonary delivery, intranasal delivery, powder aerosol, spray drying, spray freeze drying, influenza |
2 |
|
antiviral, flu a, pb2, cap-binding, fluorescence polarization |
1 |
|
virus-host interaction, antiviral discovery, transcriptional factors |
1 |
